Searched for
LAMIVUDINE
Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...- Adequate stock of antiretroviral drugs for 95% 'People Living with HIV' in India: SourcesThere is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...
- Trending stocks: Laurus Labs shares climb 4%A total of 70,447 shares changed hands on the counter till 02:31PM (IST).
- Zydus Cadila gets USFDA nod to market generic HIV treatment tabletsThe approval from the USFDA is for Abacavir and Lamivudine tablets USP in the strength of 600 mg/300 mg, Zydus Cadila said.
- Aurobindo Pharma gets nod from South African health authority for HIV drugThe approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of millions...
- Aurobindo Pharma gets USFDA nod for anti-HIV drugAurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...
- Aurobindo Pharma gets USFDA nod for HIV drug"The company has received final approval from the USFDA to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg."
- Lupin launches generic HIV drug in US marketThe company had earlier received approval from the United States Food and Drug Administration for Abacavir and Lamivudine tablets 600 mg/30...
- More cancer, HIV drugs to cost less post price capNPPA has also revised the ceiling prices of antiretroviral drugs Zidovudine (300mg) and the Lamivudine (150mg) + Zidovudine (300mg) combina...
- Semler gets WHO notice of concern over violation of ideal laboratory and clinical practicesThe WHO said its findings bring into question the validity of studies (performed for 12 products) that are under assessment, but not prequa...
- Cipla ready to launch low dose HIV drug 'Efavirenz'Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.
- Government exempts AIDS drugs from customs dutyThe exemption will benefit Anti-Retroviral Drugs (ARV Drugs) -- Adult First Line, Adult Second Line and Paediatric Drugs.
- US FDA approves sale of Strides Arcolab's HIV treatment drugStrides Arcolab said US health regulator has approved its drug used for treating HIV infection in adult and children for sale in US market.
- Lupin gets USFDA approval for HIV drugThe Mumbai-based firm has received final approval from the US Food and Drug Administration for its Lamivudine tablets in strengths of 150 m...
- Lupin, Aurobindo get USFDA nod for HIV drugDrug firms Lupin Ltd and Aurobindo Pharma today said they have received approval to sell generic Combivir tablets, used in treating HIV inf...
- Strides Arcolab receives US FDA nod for HIV drugDrug firm Strides Arcolab today said it has received tentative approval from US health regulator for fixed dose combination of Lamivudine a...
- Ranbaxy drugs in US AIDS programme under scannerThe development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.
- Cipla gets tentative approval for anti-AIDS drugsAccording to information available on the USFDA website, the tentative approval is for 150 mg of Lamivedine and 300 mg for Zidovudine.
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
- Aurobindo gets tentative USFDA nod for HIV-1 drugAurobindo Pharma on Monday said it has received a tentative New Drug Approval from USFDA for its fixed dose combination product used for tr...
Load More
